In today's world, CCR4 has become a topic of great relevance and interest to a wide variety of people. Whether due to its impact on society, its historical relevance or its influence on popular culture, CCR4 is a topic that arouses curiosity and debate in different areas. In this article, we will explore the different facets and perspectives related to CCR4, analyzing its importance and implications in today's world. Through a multidisciplinary approach, we will seek to deepen the understanding of CCR4, offering a comprehensive vision that allows readers to delve into this fascinating topic and expand their knowledge about it.
C-C chemokine receptor type 4 is a protein that in humans is encoded by the CCR4 gene.[5][6][7] CCR4 has also been designated CD194 (cluster of differentiation 194).
The protein encoded by this gene belongs to the G protein-coupled receptor family. It is a receptor for the following CC chemokines:
Chemokines are a group of small structurally related proteins that regulate cell trafficking of various types of leukocytes. The chemokines also play fundamental roles in the development, homeostasis, and function of the immune system, and they have effects on cells of the central nervous system as well as on endothelial cells involved in angiogenesis or angiostasis.[7]
CCR4 is a cell-surface protein and should not be confused with the unrelated carbon catabolite repression-negative on TATA-less (CCR4-Not), a nuclear protein complex that regulates gene expression.
CCR4 is often expressed on leukemic cells in cutaneous T-cell lymphoma (CTCL).[10]
Mogamulizumab is a humanised monoclonal antibody targeted at CCR4 and is an investigational drug for CTCL.[10]
This article incorporates text from the United States National Library of Medicine, which is in the public domain.